Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Jennifer H. Barnett"'
Autor:
Atiqul Haq Mazumder, Jennifer H. Barnett, Anu-Helmi Halt, Marjo Taivalantti, Martta Kerkelä, Marjo-Riitta Järvelin, Juha Veijola
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Light and moderate alcohol use has been reported to be associated with both impaired and enhanced cognition. The purpose of this study was to explore whether there was a linear relationship between visual memory and alcohol consumption in ma
Externí odkaz:
https://doaj.org/article/c1325a1eaf42499fba912ebf1b85f0d2
Autor:
Nick Taptiklis, Merina Su, Jennifer H. Barnett, Caroline Skirrow, Jasmin Kroll, Francesca Cormack
Publikováno v:
Frontiers in Artificial Intelligence, Vol 6 (2023)
IntroductionBiomarkers of mental effort may help to identify subtle cognitive impairments in the absence of task performance deficits. Here, we aim to detect mental effort on a verbal task, using automated voice analysis and machine learning.MethodsA
Externí odkaz:
https://doaj.org/article/c44fa8e4630746908b6d3ccc5f7f609e
Publikováno v:
Schizophrenia Research: Cognition, Vol 29, Iss , Pp 100248- (2022)
With an unmet clinical need for effective interventions for cognitive and negative symptoms in patients with schizophrenia, measures of functional status (often a co-primary endpoint) remain key clinical trial outcomes. This review aims to give an ov
Externí odkaz:
https://doaj.org/article/ff3c940aa0cb455391bfe0d0d25fd962
Autor:
Kiri T. Granger, Jennifer Ferrar, Sheryl Caswell, Mark Haselgrove, Paula M. Moran, Angela Attwood, Jennifer H. Barnett
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Stratified medicine approaches have potential to improve the efficacy of drug development for schizophrenia and other psychiatric conditions, as they have for oncology. Latent inhibition is a candidate biomarker as it demonstrates differential sensit
Externí odkaz:
https://doaj.org/article/32292e0a60684244950dc14b87b4792c
Publikováno v:
Biomarkers in Neuropsychiatry, Vol 3, Iss , Pp 100025- (2020)
The biological heterogeneity of schizophrenia continues to be a major obstacle for clinical practice and the development of novel drug treatments. A non-invasive biomarker to define sub-groups of patients with common neurobiological underpinnings wou
Externí odkaz:
https://doaj.org/article/8a7d5528b42f443ab9f56043ff1b4654
Autor:
Lisa-Marie Rutter, Eva Nouzova, David J. Stott, Christopher J. Weir, Valentina Assi, Jennifer H. Barnett, Caoimhe Clarke, Nikki Duncan, Jonathan Evans, Samantha Green, Kirsty Hendry, Meigan McGinlay, Jenny McKeever, Duncan G. Middleton, Stuart Parks, Robert Shaw, Elaine Tang, Tim Walsh, Alexander J. Weir, Elizabeth Wilson, Tara Quasim, Alasdair M.J. MacLullich, Zoë Tieges
Publikováno v:
BMC Geriatrics, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Delirium is a common and serious clinical syndrome which is often missed in routine clinical care. The core cognitive feature is inattention. We developed a novel bedside neuropsychological test for assessing inattention in deliri
Externí odkaz:
https://doaj.org/article/c057d7cec09440419e01ad6bc0297382
Publikováno v:
Frontiers in Psychiatry, Vol 10 (2019)
There are currently no regulatory approved pharmacological treatments for cognitive impairment associated with schizophrenia (CIAS). One possibility is that trial methodology itself is hindering their development. Emerging evidence suggests that pati
Externí odkaz:
https://doaj.org/article/a65ea29b483a489db768a4ea5782d363
Autor:
Jack Cotter, Jennifer H. Barnett
Publikováno v:
Frontiers in Psychiatry, Vol 9 (2018)
Externí odkaz:
https://doaj.org/article/c0c7708cd7e448d99fb812fcca74724b
Autor:
Jack Cotter, Nethmi Vithanage, Shuna Colville, Dawn Lyle, Denise Cranley, Francesca Cormack, Jennifer H. Barnett, Katy Murray, Suvankar Pal
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
Cognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been reported at all stages and in all subtypes of the disease. These deficits have been reported across a variety of cognitive domains, but are generally
Externí odkaz:
https://doaj.org/article/1c3f85169f7749c3a0d827488f0c2530
Autor:
Irina Rannikko, Graham K. Murray, Pauliina Juola, Henri Salo, Marianne Haapea, Jouko Miettunen, Juha Veijola, Jennifer H. Barnett, Anja P. Husa, Peter B. Jones, Marjo-Riitta Järvelin, Matti Isohanni, Erika Jääskeläinen
Publikováno v:
Schizophrenia Research: Cognition, Vol 2, Iss 3, Pp 120-126 (2015)
Neurocognitive dysfunction is common in schizophrenia but its course and determinants remain uncertain. Our aim was to analyse if premorbid school performance and the severity of illness and functioning predict change in cognition in schizophrenia in
Externí odkaz:
https://doaj.org/article/5da4468f4d3a434ea2ed0d69e2874c4d